The 5’UTR of HCoV-OC43 Adopts a Topologically Constrained Structure to Intrinsically Repress Translation.

RNA-targeting CRISPR research has rapidly advanced in recent years, leading to several innovative mechanisms using CRISPR in RNA therapeutics.

Basecalling directly determines what nucleotide bases are in an RNA sequence, revealing actionable characterization insights.

eSTRAND RNA QC uses direct RNA sequencing to provide multiple critical quality attributes in a single run without requiring reverse transcription or translation.

This year's mRNA-Based Therapeutics Summit proved that RNA is a platform, but drug developers must close analytical gaps to see how their constructs work.